P50HD105354
Project Grant
Overview
Grant Description
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/PENN - (Research Plan- Overall) Project Summary
With this application, we seek funding for the Intellectual and Developmental Disabilities Research Center (IDDRC) at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (PENN), which has been continuously funded for the past 30 years. Our IDDRC supports an interdisciplinary program and is the chief agency at CHOP/PENN for the promulgation of research into the intellectual and developmental disabilities (IDDS). Our mission, to identify the pathogenesis of and develop therapies for individuals with IDDS, is pursued through three aims.
(Aim 1) Lead a cutting-edge IDD research agenda. We will support five research cores that harness innovations in genetics and neuroscience to identify the causes of IDDS, to determine how gene variants alter brain structure, circuitry, and behavioral outputs (cognitive, motor, sensory, social, affective), and to utilize this information to develop biomarkers and new treatments for IDDS. Our cores deploy complementary state-of-the-art technologies, focusing on studies performed in two species (mouse & human), making it easier for center members to perform more impactful research. Cores emphasize research along the developmental spectrum. These strategies ensure that the advances will have a translational impact. The cores provide cost-effective support for 61 world-class center members, who are funded by 78 grants totaling $29.1 million annually to study the pathogenesis of IDDS, to identify new biomarkers of IDDS, and to develop novel interventions (pharmacologic and genetic). In addition, we will support an innovative research project that uses center cores to determine if magnetoencephalography (MEG) measures of auditory processing in infants at genetic risk for IDD can be used to predict cognitive and language outcome. Our cores focus on rigorous and reproducible research practices, including sound experimental design for hypothesis testing, well-justified sample sizes, and robust data analytics.
(Aim 2) Lead a multi-disciplinary career development program to support trainees and early-stage faculty. Our trainees are diverse and have PhDs, MDs, and MD/PhDs with backgrounds in genetics, neuroscience, and related disciplines. They receive support from IDDRC-administered programs: a NINDS-funded T32 training grant in neurodevelopmental disabilities, a CHOP Research Institute-funded supplement program for clinical research fellows, and a CHOP-Institute funded new program development award for assistant professors. They obtain multidisciplinary training that helps them become future leaders in IDD research.
(Aim 3) Support networking/collaboration, advocacy, and the dissemination of IDD research findings. The center leadership will enable networking to support collaborative initiatives, both within the CHOP/PENN IDDRC community and between IDDRCs. Center leadership will advocate both internally and externally to advance an IDD research agenda. Finally, the center will lead an effort to disseminate research advances to patients, their families, to government officials, and to other scientists.
With this comprehensive approach, the IDDRC at CHOP and PENN will achieve our goal of advancing patient-centered innovative treatments for individuals with IDDS.
With this application, we seek funding for the Intellectual and Developmental Disabilities Research Center (IDDRC) at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (PENN), which has been continuously funded for the past 30 years. Our IDDRC supports an interdisciplinary program and is the chief agency at CHOP/PENN for the promulgation of research into the intellectual and developmental disabilities (IDDS). Our mission, to identify the pathogenesis of and develop therapies for individuals with IDDS, is pursued through three aims.
(Aim 1) Lead a cutting-edge IDD research agenda. We will support five research cores that harness innovations in genetics and neuroscience to identify the causes of IDDS, to determine how gene variants alter brain structure, circuitry, and behavioral outputs (cognitive, motor, sensory, social, affective), and to utilize this information to develop biomarkers and new treatments for IDDS. Our cores deploy complementary state-of-the-art technologies, focusing on studies performed in two species (mouse & human), making it easier for center members to perform more impactful research. Cores emphasize research along the developmental spectrum. These strategies ensure that the advances will have a translational impact. The cores provide cost-effective support for 61 world-class center members, who are funded by 78 grants totaling $29.1 million annually to study the pathogenesis of IDDS, to identify new biomarkers of IDDS, and to develop novel interventions (pharmacologic and genetic). In addition, we will support an innovative research project that uses center cores to determine if magnetoencephalography (MEG) measures of auditory processing in infants at genetic risk for IDD can be used to predict cognitive and language outcome. Our cores focus on rigorous and reproducible research practices, including sound experimental design for hypothesis testing, well-justified sample sizes, and robust data analytics.
(Aim 2) Lead a multi-disciplinary career development program to support trainees and early-stage faculty. Our trainees are diverse and have PhDs, MDs, and MD/PhDs with backgrounds in genetics, neuroscience, and related disciplines. They receive support from IDDRC-administered programs: a NINDS-funded T32 training grant in neurodevelopmental disabilities, a CHOP Research Institute-funded supplement program for clinical research fellows, and a CHOP-Institute funded new program development award for assistant professors. They obtain multidisciplinary training that helps them become future leaders in IDD research.
(Aim 3) Support networking/collaboration, advocacy, and the dissemination of IDD research findings. The center leadership will enable networking to support collaborative initiatives, both within the CHOP/PENN IDDRC community and between IDDRCs. Center leadership will advocate both internally and externally to advance an IDD research agenda. Finally, the center will lead an effort to disseminate research advances to patients, their families, to government officials, and to other scientists.
With this comprehensive approach, the IDDRC at CHOP and PENN will achieve our goal of advancing patient-centered innovative treatments for individuals with IDDS.
Funding Goals
TO CONDUCT AND SUPPORT LABORATORY RESEARCH, CLINICAL TRIALS, AND STUDIES WITH PEOPLE THAT EXPLORE HEALTH PROCESSES. NICHD RESEARCHERS EXAMINE GROWTH AND DEVELOPMENT, BIOLOGIC AND REPRODUCTIVE FUNCTIONS, BEHAVIOR PATTERNS, AND POPULATION DYNAMICS TO PROTECT AND MAINTAIN THE HEALTH OF ALL PEOPLE. TO EXAMINE THE IMPACT OF DISABILITIES, DISEASES, AND DEFECTS ON THE LIVES OF INDIVIDUALS. WITH THIS INFORMATION, THE NICHD HOPES TO RESTORE, INCREASE, AND MAXIMIZE THE CAPABILITIES OF PEOPLE AFFECTED BY DISEASE AND INJURY. TO SPONSOR TRAINING PROGRAMS FOR SCIENTISTS, DOCTORS, AND RESEARCHERS TO ENSURE THAT NICHD RESEARCH CAN CONTINUE. BY TRAINING THESE PROFESSIONALS IN THE LATEST RESEARCH METHODS AND TECHNOLOGIES, THE NICHD WILL BE ABLE TO CONDUCT ITS RESEARCH AND MAKE HEALTH RESEARCH PROGRESS UNTIL ALL CHILDREN, ADULTS, FAMILIES, AND POPULATIONS ENJOY GOOD HEALTH. THE MISSION OF THE NICHD IS TO ENSURE THAT EVERY PERSON IS BORN HEALTHY AND WANTED, THAT WOMEN SUFFER NO HARMFUL EFFECTS FROM REPRODUCTIVE PROCESSES, AND THAT ALL CHILDREN HAVE THE CHANCE TO ACHIEVE THEIR FULL POTENTIAL FOR HEALTHY AND PRODUCTIVE LIVES, FREE FROM DISEASE OR DISABILITY, AND TO ENSURE THE HEALTH, PRODUCTIVITY, INDEPENDENCE, AND WELL-BEING OF ALL PEOPLE THROUGH OPTIMAL REHABILITATION.
Grant Program (CFDA)
Place of Performance
Philadelphia,
Pennsylvania
191044318
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 511% from $1,123,757 to $6,865,896.
The Children's Hospital Of Philadelphia was awarded
IDDRC at CHOP/PENN: Advancing IDDS Research
Project Grant P50HD105354
worth $6,865,896
from the National Institute of Allergy and Infectious Diseases in July 2021 with work to be completed primarily in Philadelphia Pennsylvania United States.
The grant
has a duration of 4 years 10 months and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Project Grant was awarded through grant opportunity Intellectual and Developmental Disabilities Reserch Centers [IDDRC] FY 2021 (P50 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
7/15/21
Start Date
5/31/26
End Date
Funding Split
$6.9M
Federal Obligation
$0.0
Non-Federal Obligation
$6.9M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for P50HD105354
Transaction History
Modifications to P50HD105354
Additional Detail
Award ID FAIN
P50HD105354
SAI Number
P50HD105354-4089964891
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NT00 NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
G7MQPLSUX1L4
Awardee CAGE
0GXU0
Performance District
PA-03
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Child Health and Human Development, National Institutes of Health, Health and Human Services (075-0844) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,382,807 | 86% |
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $400,000 | 14% |
Modified: 8/6/25